Cancer and the chemokine network

Balkwill, Fran·2004·Nature Reviews Cancer

Cited by (1,000)

Items 401–500 of 1,000

  1. Negative impact of leakage on survival of patients undergoing curative resection for advanced gastric cancer
    Han Mo Yoo, Han Hong Lee, Jung Ho Shim, Hae Myung Jeon, Cho Hyun Park, Kyo Young Song · 2011 · Journal of Surgical Oncology
  2. Perineural growth in head and neck squamous cell carcinoma: A review
    Joseph Roh, Thomas J. Muelleman, Ossama William Tawfik, Sufi Mary Thomas · 2014 · Oral Oncology
  3. Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy
    Anika Agarwal, Sarah L. Tressel, Rajani Kaimal, Marianthi Balla, Francis H. Lam, Lidija Covic, Athan Kuliopulos · 2010 · Cancer Research
  4. Nanobodies in cancer
    Elisha R. Verhaar, Andrew W. Woodham, Hidde L. Ploegh · 2020 · Seminars in Immunology
  5. CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel‐induced cytotoxicity
    David Z. Qian, Brooks L. S. Rademacher, Janét Pittsenbarger, Chung‐Ying Huang, Anne Myrthue, Celestia S. Higano, Mark G. Garzotto, Peter S. Nelson, Tomasz M. Beer · 2009 · The Prostate
  6. The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis
    Wei Zhuo, Lin Jia, Nan Song, Xin‐an Lu, Yanping Ding, Xiaofeng Wang, Xiaomin Song, Yan Fu, Yongzhang Luo · 2012 · Clinical Cancer Research
  7. The role of tumor-associated macrophages in tumor vascularization
    Chunqing Guo, Annicole Buranych, Devanand Sarkar, Paul B. Fisher, Xiang‐Yang Wang · 2013 · Vascular Cell
  8. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases
    Sébastien Tabariès, Véronique Ouellet, Brian E. Hsu, Matthew G. Annis, April A. N. Rose, Liliane Meunier, Eurı́dice Carmona, Christine Tam, Anne‐Marie Mes‐Masson, Peter M. Siegel · 2015 · Breast Cancer Research
  9. Manipulating the chemokine‐chemokine receptor network to treat cancer
    Pier Adelchi Ruffini, Paolo Morandi, Neslihan Cabıoğlu, Kadri Altundağ, Massimo Cristofanilli · 2007 · Cancer
  10. Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1
    Jamie L. McClellan, J. Mark Davis, Jennifer L. Steiner, Reilly T. Enos, Seung Ho Jung, James A. Carson, Maria Marjorette O. Peña, Kevin A. Carnevale, Franklin G. Berger, E. Angela Murphy · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  11. Liposomes in Biology and Medicine
    Reto Albert Schwendener · 2007 · Advances in experimental medicine and biology
  12. GPCRs and cancer
    Rosamaria Lappano, Marcello Maggiolini · 2012 · Acta Pharmacologica Sinica
  13. Development of a bifunctional nanobiosensor for screening and detection of chemokine ligand in colorectal cancer cell line
    Saeromi Chung, Pranjal Chandra, Jaseok Peter Koo, Yoon‐Bo Shim · 2017 · Biosensors and Bioelectronics
  14. Secretory microRNAs as biomarkers of cancer
    Kazuharu Kai, Rachel L. Dittmar, Subrata Sen · 2017 · Seminars in Cell and Developmental Biology
  15. Tumor-host interactions: the role of inflammation
    Marie‐Aude Le Bitoux, Ivan Stamenkovic · 2008 · Histochemistry and Cell Biology
  16. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis
    Pradeep Bist, Shing Leow, Qian‐Hui Phua, Shin La Shu, Qiu-Shi Zhuang, Woei-Shyang Loh, Thanh Nguyen, Jianbiao Zhou, Shing Chuan Hooi, Lina H. K. Lim · 2011 · Oncogene
  17. TNF-α Induces Epithelial–Mesenchymal Transition of Renal Cell Carcinoma Cells via a GSK3β-Dependent Mechanism
    Ming-Yi Ho, Shye‐Jye Tang, Mei‐Jen Chuang, Tai‐Lung Cha, Jing-Yao Li, Guang-Huan Sun, Kuang‐Hui Sun · 2012 · Molecular Cancer Research
  18. Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth
    Shuchismita R. Satpathy, Venkatakrishna Rao Jala, Sobha Rani Bodduluri, Elangovan Krishnan, Bindu Hegde, Gary W. Hoyle, Mostafa Fraig, Andrew David Luster, Bodduluri Haribabu · 2015 · Nature Communications
  19. Association Between Circulating White Blood Cell Count and Cancer Mortality
    Anoop Shankar, Jie Jin Wang, Elena Rochtchina, Mimi C. Yu, Richard F. Kefford, Paul Mitchell · 2006 · Archives of Internal Medicine
  20. The Hydra Phenomenon of Cancer: Why Tumors Recur Locally after Microscopically Complete Resection
    Michael Höckel, Nadja Dornhöfer · 2005 · Cancer Research
  21. Future directions of bone-targeted therapy for metastatic breast cancer
    Tomifumi Onishi, Naoki Hayashi, Richard L. Theriault, Gabriel N. Hortobágyi, Naoto Tada Ueno · 2010 · Nature Reviews Clinical Oncology
  22. Down-regulation of CXCL5 Inhibits Squamous Carcinogenesis
    Hiroshi Miyazaki, Vyomesh Patel, Hui‐Xin Wang, Ryan K. Edmunds, Jorge Silvio Gutkind, William Andrew Yeudall · 2006 · Cancer Research
  23. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression
    Fee Bengsch, Achim Buck, Sira Carolin Günther, Julia R. Seiz, Marlene Tacke, Dietmar Pfeifer, Dominik von Elverfeldt, Lisa Sevenich, Larissa Elisabeth Hillebrand, Ursula Kern et al. · 2013 · Oncogene
  24. Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
    Binghao Li, Zhan Wang, Hao Wu, Mingfeng Xue, Peng Lin, Shengdong Wang, Nong Lin, Xin Huang, Weibo Pan, Meng Liu et al. · 2018 · Cancer Research
  25. Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway
    Z Wang, Qingyong Ma, Q Liu, Hai Yu, Lin Zhao, Sugang Shen, Juntao Yao · 2008 · British Journal of Cancer
  26. Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
    Massimo Zollo, Valeria Di Dato, Daniela Spano, Daniela De Martino, Lucia Liguori, Natascia Marino, Viviana Vastolo, Luigi Navas, Beatrice Garrone, Giorgina Mangano et al. · 2012 · Clinical & Experimental Metastasis
  27. The Role of Inflammation in Kidney Cancer
    Antonio Roma de Vivar Chevez, James Harold Finke, Ronald M. Bukowski · 2014 · Advances in experimental medicine and biology
  28. CCL3 Signaling in the Tumor Microenvironment
    Ioannis Ntanasis‐Stathopoulos, Despina Fotiou, Evangelos Terpos · 2020 · Advances in experimental medicine and biology
  29. LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
    Jingqi Shi, Dongbo Jiang, Shuya Yang, Xiyang Zhang, Jing Wang, Yang Liu, Yuanjie Sun, Yuchen Lu, Kun Yang · 2020 · Frontiers in Oncology
  30. COX-2 and Prostaglandin EP3/EP4 Signaling Regulate the Tumor Stromal Proangiogenic Microenvironment via CXCL12-CXCR4 Chemokine Systems
    Hiroshi Katoh, Kanako Hosono, Yoshiya Ito, Tatsunori Suzuki, Yasufumi Ogawa, Hidefumi Kubo, Hiroki Kamata, Toshiaki Mishima, Hideaki Tamaki, Hiroyuki Sakagami et al. · 2010 · American Journal Of Pathology
  31. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction
    Mingzhu Huang, Yuqing Li, Huanle Zhang, Feifei Nan · 2010 · Journal of Experimental & Clinical Cancer Research
  32. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
    Nissar Ahmad Wani, Mohd Wasim Nasser, Dinesh Kumar Ahirwar, Helong Zhao, Zhenhua Miao, Konstantin Shilo, Ramesh Kumar Ganju · 2014 · Breast Cancer Research
  33. TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence
    Ilana Chefetz, Ayesha B. Alvero, Jennie C. Holmberg, Noah Lebowitz, Vinicius Craveiro, Yang Yang‐Hartwich, Gang Yin, Lisa Squillace, Marta Gurrea Soteras, Paulomi Bole Aldo et al. · 2013 · Cell Cycle
  34. An Up-date of Olive Oil Phenols in Inflammation and Cancer: Molecular Mechanisms and Clinical Implications
    Ana Cárdeno, Marina Sánchéz‐Hidalgo, Catalina Alarcón‐de‐la‐Lastra · 2013 · Current Medicinal Chemistry
  35. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion
    Sachin Mehta, Kent W. Christopherson, Poornima Bhat‐Nakshatri, Robert J. Goulet, Hal E. Broxmeyer, Levy Kopelovich, Harikrishna Nakshatri · 2006 · Oncogene
  36. The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis
    Stefania Gelmini, Monica Mangoni, M. Serio, Paola Romagnani, Elena Lazzeri · 2008 · Journal of Endocrinological Investigation
  37. Chemokine (C-C Motif) Ligand 2 Mediates the Prometastatic Effect of Dysadherin in Human Breast Cancer Cells
    Jeong‐Seok Nam, Mi‐Jin Kang, Adam M. Suchar, Takeshi Shimamura, Ethan A. Kohn, Aleksandra M. Michalowska, Virgil Craig Jordan, Setsuo Hirohashi, Lalage M. Wakefield · 2006 · Cancer Research
  38. Phosphorylation of Mammalian Cytochrome c and Cytochrome c Oxidase in the Regulation of Cell Destiny: Respiration, Apoptosis, and Human Disease
    Maik Hüttemann, Icksoo Lee, Lawrence I. Grossman, Jeffrey W. Doan, Thomas H. Sanderson · 2012 · Advances in experimental medicine and biology
  39. The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression
    Balsam R. Rizeq, Mohammed Imad Malki · 2020 · Cancers
  40. C6 cell line: the gold standard in glioma research.
    Dimitrios Giakoumettis, Aristeidis Κritis, Nikolaos Foroglou · 2018 · PubMed Central
  41. Cancer-associated Fibroblasts induce epithelial-mesenchymal transition via the Transglutaminase 2-dependent IL-6/IL6R/STAT3 axis in Hepatocellular Carcinoma
    Changchang Jia, Guoying Wang, Tiantian Wang, Binsheng Fu, Yincai Zhang, Lei Huang, Yinan Deng, Guanzhong Chen, Xiaocai Wu, Jianning Chen et al. · 2020 · International Journal of Biological Sciences
  42. Tumor-associated macrophages in pancreatic ductal adenocarcinoma: therapeutic opportunities and clinical challenges
    Poh, Ashleigh R., Ernst, Matthias · 2021 · Cancers
  43. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma
    Silky Rajesh Punyani, Ramhari Shankarrao Sathawane · 2012 · Clinical Oral Investigations
  44. Prospective Study of Leukocyte Count as a Predictor of Incident Breast, Colorectal, Endometrial, and Lung Cancer and Mortality in Postmenopausal Women
    Karen L. Margolis · 2007 · Archives of Internal Medicine
  45. Control of senescence by CXCR2 and its ligands
    Acosta, Juan C., Loghlen, Ana, Banito, Ana, Raguz, Selina, Gil, Jesús · 2008 · Cell Cycle
  46. Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives
    Jong Hyuk Kim, Ashley J. Graef, Erin B. Dickerson, Jaime F. Modiano · 2015 · Veterinary Sciences
  47. Interleukin-17-induced EMT promotes lung cancer cell migration and invasion via NF-κB/ZEB1 signal pathway.
    Kuo Gu, Mingming Li, Jing Shen, Fang Liu, Jingyan Cao, Shi Jin, Yan Yu · 2015 · PubMed Central
  48. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways
    Yeo Song Lee, So-Young Kim, Hye Kyung Hong, Hye Kyung Hong, Yura Lee, Bo Young Oh, Woo Yong Lee, Yong Beom Cho · 2016 · Oncotarget
  49. Proinflammatory CXCL12–CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice
    Achinto Saha, Songyeon Ahn, Jorge M. Blando, Fei Su, Mikhail G. Kolonin, John DiGiovanni · 2017 · Cancer Research
  50. Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types
    Monique K. van der Kooij, Frank M. Speetjens, Sjoerd H. van der Burg, Ellen Kapiteijn · 2019 · Cancers
  51. CCR2 is required for CD8-induced graft-versus-host disease
    Theis H. Terwey, Theo Daniel Kim, Adam A. Kochman, Vanessa M. Hubbard, Sydney X. Lu, Johannes L. Zakrzewski, Teresa Ramirez‐Montagut, Jeffrey M. Eng, Stephanie J. Muriglan, Glenn Heller et al. · 2005 · Blood
  52. Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities
    Noemí Eiró, Luis O. González, María Fraile, Sandra Cid, José Schneider, Francisco José Vizoso · 2019 · Cancers
  53. Regulation and functional roles of chemokines in liver diseases
    Sheng Cao, Mengfei Liu, Tejasav S. Sehrawat, Vijay H. Shah · 2021 · Nature Reviews Gastroenterology & Hepatology
  54. CXCL5 overexpression is associated with late stage gastric cancer
    Jeong Youp Park, Kyong Hwa Park, Seungmin Bang, Myoung‐Hwan Kim, Ji-Eun Lee, Jingu Gang, Sang Seok Koh, Si Young Song · 2007 · Journal of Cancer Research and Clinical Oncology
  55. Pharmacological and toxicological activities of α-humulene and its isomers: A systematic review
    Giovana Mendes de Lacerda, Maysa de Oliveira Barbosa, Maria Janice Pereira Lopes, Gyllyandeson de Araújo Delmondes, Daniel Souza Bezerra, Isaac Moura Araújo, Cícero Damon Carvalho de Alencar, Henrique Douglas Melo Coutinho, Laisla Rangel Peixoto, José Maria Barbosa‐Filho et al. · 2021 · Trends in Food Science & Technology
  56. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma
    Georg C. Hutterer, Caroline Stoeckigt, Tatjana Stojaković, Johanna Jesche, Katharina Eberhard, Karl Pummer, Richard E. Zigeuner, Martin Pichler · 2014 · Urologic Oncology Seminars and Original Investigations
  57. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity
    Monica Gatti, Alessandra Pattarozzi, Adriana Bajetto, Roberto Würth, Antonio Daga, Pietro Fiaschi, Gianluigi Zona, Tullio Florio, Federica Barbieri · 2013 · Toxicology
  58. Obesity-Related Digestive Diseases and Their Pathophysiology
    Su Youn Nam · 2016 · Gut and Liver
  59. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics
    Georgia Karpathiou, François Casteillo, Jean-Baptiste Giroult, Fabien Forest, P. Fournel, Alessandra Monaya, Μarios E. Froudarakis, Jean Marc Dumollard, Jean Michel Prades, Michel Péoc’h · 2016 · Oncotarget
  60. Horizontal transfer of exosomal CXCR4 promotes murine hepatocarcinoma cell migration, invasion and lymphangiogenesis
    Min Li, Ying Lü, Yunchao Xu, Jingwen Wang, Chenghong Zhang, Yue Du, Lu Wang, Lianhong Li, Bo Wang, Jie Shen et al. · 2018 · Gene
  61. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer
    Federica Marchesi, Marco Locatelli, Graziella Solinas, Marco Erreni, Paola Allavena, Alberto Mantovani · 2010 · Journal of Neuroimmunology
  62. Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer
    Chuen‐Ming Shih, Yao-Ling Lee, Hui‐Ling Chiou, Wei Chen, Gee‐Chen Chang, Ming‐Chih Chou, Long‐Yau Lin · 2006 · Lung Cancer
  63. Interplay of distinct growth factors during epithelial–mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies
    Murielle Mimeault, Surinder K. Batra · 2007 · Annals of Oncology
  64. CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
    Li Li, Li Xu, Jing Yan, Zuo-Jun Zhen, Yong Ji, Chao-Qun Liu, Wan Yee Lau, Limin Zheng, Jing Xu · 2015 · Journal of Experimental & Clinical Cancer Research
  65. Microenvironmental influences of apoptosis in vivo and in vitro
    Christopher D. Gregory, John D. Pound · 2010 · APOPTOSIS
  66. Proteolytic processing of chemokines: Implications in physiological and pathological conditions
    Marlene Wolf, Stefan Albrecht, C. Märki · 2008 · The International Journal of Biochemistry & Cell Biology
  67. Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)
    Hidetoshi Nitta, Yoshihiro Wada, Yoshiaki Kawano, Yoji Murakami, Atsushi Irie, Keisuke Taniguchi, Ken Kikuchi, Gen Yamada, Kentaro Suzuki, Jiro Honda et al. · 2013 · Clinical Cancer Research
  68. Phagocytes as Corrupted Policemen in Cancer-Related Inflammation
    Eduardo Bonavita, Maria Rosaria Galdiero, Sébastien Jaillon, Alberto Mantovani · 2015 · Advances in cancer research
  69. A meta-analysis of CXCL12 expression for cancer prognosis
    Harsh Samarendra, Keaton Ian Jones, Tatjana Petrinic, Michael A. Silva, Srikanth Reddy, Zahir F. Soonawalla, Alex Nicolas Gordon-Weeks · 2017 · British Journal of Cancer
  70. Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients
    Yann Alexandre Vano, Stéphane Marie. Oudard, Marie-Agnès By, Pauline Tétu, Constance Thibault, Haïl Aboudagga, Florian Scotté, Réza Elaidi · 2018 · PLoS ONE
  71. NF-κB: Governing Macrophages in Cancer
    Jessica Cornice, Daniela Verzella, Paola Arboretto, Davide Vecchiotti, Daria Capece, Francesca Zazzeroni, Guido Franzoso · 2024 · Genes
  72. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
    Nathan Reynders, Dayana Abboud, Alessandra Baragli, Muhammad Zaeem Noman, Bernard Rogister, Simone P. Niclou, Nikolaus Heveker, Bassam Janji, Julien Hanson, Martyna Szpakowska et al. · 2019 · Cells
  73. CXCL14 expression and potential function in pancreatic cancer
    Moritz N. Wente, Christine Mayer, Matthias M. Gaida, Christoph W. Michalski, Thomas Giese, Frank Bergmann, Nathalia A. Giese, Markus Wolfgang Büchler, Helmut Friess · 2007 · Cancer Letters
  74. Tumor-Associated Macrophages as Incessant Builders and Destroyers of the Cancer Stroma
    Manuela Liguori, Graziella Solinas, Giovanni Germano, Alberto Mantovani, Paola Allavena · 2011 · Cancers
  75. Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway
    Christian Korherr, Hendrik Gille, Rolf Schäfer, Kerstin Koenig‐Hoffmann, Johan Dixelius, Kristi A. Egland, Ira H Pastan, Ulrich Brinkmann · 2006 · Proceedings of the National Academy of Sciences
  76. ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity
    Matteo Massara, Ornella Bonavita, Benedetta Savino, Nicoletta Caronni, Valeria Mollica Poeta, Marina Sironi, Elisa Setten, Camilla Recordati, Laura Crisafulli, Francesca Ficara et al. · 2018 · Nature Communications
  77. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma
    Shannon Coy, Shu Wang, Sylwia A. Stopka, Jia‐Ren Lin, Clarence Yapp, Cecily C. Ritch, Lisa Salhi, Gregory J. Baker, Rumana Rashid, Gerard Baquer et al. · 2022 · Nature Communications
  78. Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma
    Hiroshi Yasui, Teru Hideshima, Paul Gerard Guy Richardson, Kenneth Carl Anderson · 2005 · British Journal of Haematology
  79. CXCL14 is a natural inhibitor of the CXCL12–CXCR4 signaling axis
    Kosuke Tanegashima, Kenji S. SUZUKI, Yuki Nakayama, Kohei Tsuji, Akira Shigenaga, Akira Otaka, Takahiko Hara · 2013 · FEBS Letters
  80. Chapter 5 Expression of Chemokines and Chemokine Receptors in Human Colon Cancer
    Marco Erreni, Paolo Pietro Bianchi, Luigi Laghi, Massimiliano Mirolo, Marco Fabbri, Massimo Locati, Alberto Mantovani, Paola Allavena · 2009 · Methods in enzymology on CD-ROM/Methods in enzymology
  81. Characterization of an adaptive immune response in microsatellite-instable colorectal cancer
    Florence Boissière‐Michot, Gwendal Lazennec, Hélène Frugier, Marta Jarlier, Lise Roca, Jacqueline Duffour, Emilie Du Paty, Daniel Laune, France Blanchard, Florence Le Pessot et al. · 2014 · OncoImmunology
  82. The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution
    Guizhen Wang, Xin Cheng, Bo Zhou, Zhesheng Wen, Yunchao Huang, Hao-Bin Chen, Gaofeng Li, Zhi-Liang Huang, Yongchun Zhou, Lin Feng et al. · 2015 · eLife
  83. Profiling Functional and Biochemical Phenotypes of Circulating Tumor Cells Using a Two‐Dimensional Sorting Device
    Mahla Poudineh, Mahmoud Labib, Sharif Uddin Ahmed, Luan N. M. Nguyen, Leyla Kermanshah, Reza M. Mohamadi, Edward Hartley Sargent, Shana O. Kelley · 2016 · Angewandte Chemie International Edition
  84. Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges
    María Vela, Mariana Aris, Mercedes Llorente, José A. García‐Sanz, Leonor Kremer · 2015 · Frontiers in Immunology
  85. Endocytic trafficking of chemokine receptors
    Adriano Marchese · 2013 · Current Opinion in Cell Biology
  86. From single cells to tissue architecture—a bottom-up approach to modelling the spatio-temporal organisation of complex multi-cellular systems
    Joerg Galle, M. Hoffmann, Gabriela Aust · 2008 · Journal of Mathematical Biology
  87. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies
    Amnon Peled, Shiri Klein, Katia Beider, Jan A. Burger, Michal Abraham · 2018 · Cytokine
  88. TNFα-exposed Bone Marrow-derived Mesenchymal Stem Cells Promote Locomotion of MDA-MB-231 Breast Cancer Cells through Transcriptional Activation of CXCR3 Ligand Chemokines
    Soon Young Shin, Jeong‐Seok Nam, Yoongho Lim, Young Han Lee · 2010 · Journal of Biological Chemistry
  89. Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF‐β dependent fashion
    Mario Mikula, Verena Proell, A.N.M. Fischer, Wolfgang Mikulits · 2006 · Journal of Cellular Physiology
  90. RETRACTED: HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB
    Paola Maroni, Paola Bendinelli, Emanuela Matteucci, Maria Alfonsina Desiderio · 2006 · Carcinogenesis · Retracted
  91. VEGF Receptor Inhibitors Block the Ability of Metronomically Dosed Cyclophosphamide to Activate Innate Immunity–Induced Tumor Regression
    Joshua C. Doloff, David J. Waxman · 2012 · Cancer Research
  92. Potential of CXCR4 antagonists for the treatment of metastatic lung cancer
    Jan A. Burger, David J. Stewart, Ori Wald, Amnon Peled · 2011 · Expert Review of Anticancer Therapy
  93. Tumor Promotion by Tumor-Associated Macrophages
    Porta, Chiara, Kumar, Biswas Subhra, Larghi, Paola, Rubino, Luca, Mancino, Alessandra, Sica, Antonio · 2007 · Advances In Experimental Medicine And Biology
  94. Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs)
    Antonio Sica, Chiara Porta, Sara Morlacchi, Stefania Banfi, Laura Strauss, Monica Rimoldi, Maria Grazia Totaro, Elena Riboldi · 2011 · Cancer Microenvironment
  95. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures
    Daruka Mahadevan, Catherine M. Spier, Kimiko Della Croce, Susan J. Miller, Benjamin L. George, Christopher Riley, Stephen H. Warner, Thomas M. Grogan, Thomas P. Miller · 2005 · Molecular Cancer Therapeutics
  96. Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration
    Junichi Yuasa‐Kawada, Mariko Kinoshita-Kawada, Yi Rao, Jane Y. Wu · 2009 · Proceedings of the National Academy of Sciences
  97. Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1α Activation in Human Osteosarcoma
    Mingjun Guo, Chengkui Cai, Guangyi Zhao, Xiuchun Qiu, Haien Zhao, Qiong Ma, Liying Tian, Xue‐Lian Li, Yunsheng Hu, Bo Liao et al. · 2014 · PLoS ONE
  98. The Chemokine CXCL8 in Carcinogenesis and Drug Response
    Dominique N. Gales, Clarence E. Clark, Upender Manne, Temesgen Samuel · 2013 · ISRN Oncology
  99. Inhibition of Chemokine (CXC Motif) Ligand 12/Chemokine (CXC Motif) Receptor 4 Axis (CXCL12/CXCR4)-mediated Cell Migration by Targeting Mammalian Target of Rapamycin (mTOR) Pathway in Human Gastric Carcinoma Cells
    Guang Chen, Si-Meng Chen, Xiang Wang, Xiaofei Ding, Jian Hua Ding, Linghua Meng · 2012 · Journal of Biological Chemistry
  100. CXCL12 G801A Polymorphism Is a Risk Factor for Sporadic Prostate Cancer Susceptibility
    Hiroshi Hirata, Yuji Hinoda, Nobuyuki Kikuno, Ken Kawamoto, Angela V. Dahiya, Yutaka Suehiro, Yuichiro Tanaka, Rajvir Dahiya · 2007 · Clinical Cancer Research